The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells-Reference-Cited by-同舟云学术

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells

Published:2010-07-06 Issue:2 Volume:127 Page:385-396
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Thiruchelvam Paul T. R.,Lai Chun-Fui,Hua Hui,Thomas Ross S.,Hurtado Antoni,Hudson William,Bayly Andrew R.,Kyle Fiona J.,Periyasamy Manikandan,Photiou Andrew,Spivey Alan C.,Ortlund Eric A.,Whitby Richard J.,Carroll Jason S.,Coombes R. Charles,Buluwela Laki,Ali Simak

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0994-9.pdf

Reference40 articles.

1. Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339(22):1609–1618

2. Ali S, Coombes RC (2002) Endocrine-responsive breast cancer and strategies for combatting resistance. Nat Rev Cancer 2:101–112

3. Johnston SR, Dowsett M (2003) Aromatase inhibitors for breast cancer: lessons from the laboratory. Nat Rev Cancer 3(11):821–831

4. Chen S et al (2006) What do we know about the mechanisms of aromatase inhibitor resistance? J Steroid Biochem Mol Biol 102(1–5):232–240

5. Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20(3):358–417

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver receptor homolog-1: structures, related diseases, and drug discovery;Acta Pharmacologica Sinica;2024-04-17

2. Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death;Cell Reports;2023-12

3. Liver Receptor Homolog-1 (LRH-1/NR5A2) orchestrates hepatic inflammation and TNF-induced cell death;2023-05-24

4. Landscape of NcRNAs involved in drug resistance of breast cancer;Clinical and Translational Oncology;2023-04-17

5. Differential Modulation of Nuclear Receptor LRH-1 through Targeting Buried and Surface Regions of the Binding Pocket;Journal of Medicinal Chemistry;2022-05-03